Pharmacokinetic-Pharmacodynamic Analysis of Lopinavir-Ritonavir in Combination with Efavirenz and Two Nucleoside Reverse Transcriptase Inhibitors in Extensively Pretreated Human Immunodeficiency Virus-Infected Patients

A. Hsu, J. Isaacson, S. Brun, B. Bernstein, W. Lam, R. Bertz, C. Foit, K. Rynkiewicz, B. Richards, M. King, R. Rode, D. J. Kempf, G. R. Granneman, E. Sun
  • Antimicrobial Agents and Chemotherapy, January 2003, ASM Journals
  • DOI: 10.1128/aac.47.1.350-359.2003
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Allison M Kitten

In partnership with: